Stimulation of 1-(beta-D-arabinofuranosyl)cytosine (AraC)-induced apoptosis in the multidrug resistant human promyelocytic leukemia cell lines with protein kinase inhibitors

Neoplasma

Volumn 43, Issue 5, 1996, Pages 291-295

  Hunakova L ^a   Sulikova M ^a   Duraj, J ^a   Sedlak J ^a   Chorvath B ^a  

^a Cancer Research Institute   (Slovakia)

Author keywords

apoptosis; AraC; CGP 41251 genistein; flow cytometry; human leukemia HL 60; multidrug resistant; protein kinase inhibitors; staurosporine

Indexed keywords

CYTARABINE; GENISTEIN; MIDOSTAURIN; PROTEIN KINASE INHIBITOR; STAUROSPORINE;

APOPTOSIS; ARTICLE; CELL STRAIN HL 60; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; MULTIDRUG RESISTANCE;

EID: 0029857353     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. ANDREJAUSKAS-BUCHDUNGER, E., REGENASS, U.: Differential inhibition of the epidermal growth factor-, platelet derived growth factor-, and protein kinase C-mediated transduction pathways by the staurosporine derivative CGP 41 251. Cancer Res., 52, 1992, 5353-5358.
2. BEHRENS, M.M., MARTINEZ, J.L., MORATILLA, C., RENART, J.: Apoptosis induced by protein kinase C inhibition in a neuroblastoma cell line. Cell Growth Differ., 6, 1995, 1373-1380.
3. BERÁNEK, J., BROKEŠ, J., HŘEBABECKÝ, H.: Preparation of 1-beta-arabinofuranosylcytosine. Czech Patent 1502, 1977.
4. CHORVÁTH, B., SEDLÁK, J., NOVOTNÝ, L.: The protein kinase C inhibitor CGP 41 251 reverses decreased daunomycin uptake in a human drug-resistant ovarian carcinoma cell line. Int. J. Cancer, 59, 1994, 852-853.
5. CHORVÁTH, B., SEDLÁK, J.: Protein kinase inhibitors: Induction of apoptosis and drug resistance modulation in neoplastic cell lines. Minireview. Neoplasma, 43, 1996, 3-9.
6. COHEN, J.J., DUKE, R.C.: Glucocorticoid activation of a calcium-dependent endonuclease in thymocyte model leads to cell death. J. Immunol., 132, 1984, 38-42.
7. COHEN, G.M., SUN, X.M., SNOWDEN, R.R., DINSDALE, D., SKILLETER, D.N.: Key morphological features of apoptosis may occur in the absence of internucleosomal DNA fragmentation. Biochem. J., 286, 1992, 331-336.
8. COTTER, T.G., LENNON, S.V., CLYNN, J.M., GREEN, D.R.: Microfilament disrupting agents prevents the formation of apoptotic bodies in tumor cells undergoing apoptosis. Cancer Res., 52, 1992, 997-1005.
9. COSSARIZZA, A., FRANCESCHI, C., MONTI, D., SALVIOLI, S., BELLESIA, E., RIVABENE, R., BIONDO, L., RAINALDI, G., TINARI, A., MALORNI, W.: Protective effect of N-acetylcysteine in TNF alpha-induced apoptosis in U-937 cells: The role of mitochondria. Exp. Cell Res., 220, 1995, 232-240.
10. DAO, T., ARIYASU, T., MICALEFF, M., MINOWADA, J.: Tumor necrosis factor-alpha induces apoptosis in human leukemia T cell line MOLT-16: Its relation to bcl-2 and c-myc expression. Int. J. Oncol., 4, 1994, 1471-1475.
11. DOLZHANSKY, A., BASCH, R.S.: Flow cytometric determination of apoptosis in heterogenous cell populations. J. Immunol. Meth., 180, 1993, 131-140.
12. EFFERTH, T., FABRY, U., GLATTE, P., OSIEKA, R.: Expression of apoptosis-related oncoproteins and modulation of apoptosis by caffeine in human leukemic cells. J. Cancer Res. Clin. Oncol., 121, 1955, 468-656.
13. CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res., 54, 1994, 1169-1174.
14. FISHER, D.E.: Apoptosis in cancer therapy: Crossing the threshold. Cell, 78, 1994, 539-542.
15. GANGEMI, R.M.R., TISO, M., MARCHETTI, C., BARGELLESI, M., SEVERI, A., FABBI, M.: Taxol cytotoxicity on human leukemia cell lines is a function of their susceptibility to programmed cell death. Cancer Chemother. Pharmacol., 36, 1995, 385-392.
16. GORCYCZA, W., GONG, J., ARDELT, B., TRAGANOS, F., DARZYNKIEWICZ, Z.: The cell cycle-related differences in susceptibility of HL-60 cells to apoptosis induced by various antitumor agents. Cancer Res., 52, 1992, 6270-6278.
17. GRANT, S., TURNER, A.J., BARTIMOLE, T.N., NELMS, P.A., JOE, V.C., JARVIS, W.D.: Modulation of 1-(beta-D-arabinofuranosyl) cytosine-induced apoptosis in human myeloid leukemia cells by staurosporine and other pharmacological inhibitors of protein kinase C. Oncol. Res., 6, 1994, 87-99.
18. HALICKA, H.D., ARDELT, B., LI, X., MELAMED, M.M., DARZYNKIEWICZ, Z.: Deoxy-D-glucose enhances sensitivity of human histiocytic lymphoma U937 cells to apoptosis induced by tumor necrosis factor. Cancer Res., 55, 1995, 444-449.
19. HUANG, P., PLUNKETT, W.: Induction of apoptosis by gemcitabine. Semin. Oncol., 22, 1995, 19-25.
20. HUNÁKOVÁ, L., SEDLÁK, J., KLOBUŠICKÁ, M., CHORVÁTH, B.: Phorbol ester (TPA)-induced differential modulation of cell surface antigens in pluripotential leukemia (K-562) cell line: Effects of protein kinase inhibitors with broad- and PKC-selective inhibitory activity. Neoplasma, 42, 1995, 249-253.
21. JARVIS, W.D., TURNER, A.J., POVIRK, L.F., TRAYLOR, R.S., GRANT, S.: Induction of apoptotic DNA fragmentation and cell death in HL-60 human promyelocytic leukemia cells by pharmacological inhibitors of protein kinase C. Cancer Res., 54, 1994, 1707-1714.
22. JEOUNG, D.I., TANG, B., SONENBERG, M.: Induction of tumor suppressor p21 protein by kinase inhibitors in MCF-7 cells. Biochem. Biophys. Res. Commun., 214, 1995, 361-366.
23. JIANG, B., LI, D.D., ZHEN, Y.: Induction of apoptosis by enediyne antitumor antibiotic C1027 in HL-60 human promyelocytic leukemia cells. Biochem. Biophys. Res. Commun., 208, 1995, 238-244.
24. KRISHNAMACHARY, N., CENTER, M.S.: The MRP-gene associated with a non-P glycoprotein multidrug resistance encodes a 190 kDa membrane bound glycoprotein. Cancer Res., 53, 1993, 3658-3661.
25. MARSH, W., SICHERI, D., CENTER, M.S.: Isolation and characterization of adriamycin-resistant HL-60 cells which are not defective in the initial accumulation of drug. Cancer Res., 46, 1996, 4053-4057.
26. MCGRATH, T., LATOUD, C., ARNOLD, S.T., SAFA, A.R., FELSTED, R.L., CENTER, M.S.: Mechanisms of multidrug resistance in HL-60 cells: Analysis of resistance associated membrane proteins and levels of MDR gene expression. Biochem. Pharmacol., 38, 1989, 3611-3619.
27. MEYER, T., REGENASS, U., FABBRO, D., ALTERI, E., ROSSEL, J., MULLER, M., CARAVATTI, G., MATTER, A.: A derivative of staurosporine (CGP 41 251) shows selectivity for protein kinase C inhibition and in vitro anti-proliferative as well as in vivo anti-tumor activity. Int. J. Cancer, 43, 1989, 851-856.
28. OBERHAMMER, F., WILSON, J.W., DIVE, C., MORRIS, I.D., HICKMAN, J.A., WAKELING, A.E., WALKER, P.R., SIKORSKA, M.: Apoptotic death in epithelial cells: Cleavage of DNA to 300 and/or 50 kb fragments prior to or in the absence of internucleosomal fragmentation. EMBO J., 12, 1993, 3679-3684.
29. PONGRACZ, J., TUFFLEY, W., JOHNSON, G.D., DEACON, E.M., BURNETT, D., STOCKLEY, R.A., LORD, J.M.: Changes in protein C isoenzyme expression associated with apoptosis in U937 myelomonocytic cells. Exp. Cell Res., 218, 1995, 430-438.
30. SEDLÁK, J., HUNÁKOVÁ, L., DURAJ, J., CHORVÁTH, B., NOVOTNÝ, L.: Effects of protein kinase C inhibitor, staurosporine derivative CGP 41 251, on cell cycle DNA synthesis and drug uptake in neoplastic cell lines. Anti-Cancer Drugs, 6, 1995, 70-76.
31. SEDLÁK, J., ŠULIKOVÁ, M., HUNÁKOVÁ, L., CHORVÁTH, B.: Differential effects of protein kinase inhibitors (staurosporine and CGP 41 251) on TPA-induced homotypic aggregation and cell surface adhesion antigen expression in human monoblastoid U-937 cell line. Neoplasma, 42, 1995, 159-165.
32. SELLINS, K.S., COHEN, J.J.: Gene induction by gamma-irradiation leads to DNA fragmentation in lymphocytes. J. Immunol., 139, 1987, 3199-3206.
33. WAF1/CIP1/ induces growth arrest, giant cell formation and apoptosis in human breast carcinoma cell lines. Oncogene, 11, 1995, 1899-1908.
34. TRAGANOS, F., KAPUSCINSKI, J., GONG, J., ARDELT, B., DARZYNKIEWICZ, R.J., DARZYNKIEWICZ, Z.: Caffeine prevents apoptosis and cell cycle effects induced by camptothecin and topotecan in HL-60 cells. Cancer Res., 53, 1993, 4613-4618.
35. TRAUTH, B.C., KLAS, C., PETERS, A.M.J., MATZKU, S., MOLLER, P., FALK, W., DEBATIN, K.M., KRAMMER, P.H.: Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science, 245, 1989, 301-304.
36. TURLEY, J.M., FUNAKOSHI, S., RUSCETT, F.W., KASPER, J., MURPHY, W.J., LONGO, D.L., BIRCHENALL-ROBERTS, M.: Growth inhibition an apoptosis of RL human B-lymphoma cells by vitamin E succinate and retinoic acid: Role for transforming factor beta. Cell Growth Differ., 6, 1995, 655-663.
37. UTZ, I., HOFER, S., REGENASS, U., HILBE, E., THALER, J., GRUNICKE, H., HOFMANN, J.: The protein kinase inhibitor CGP 41 251, a staurosporine derivative with anti-tumor activity, reverses multidrug resistance. Int J. Cancer, 57, 1994, 104-110.
38. ZIMMERMANN, A., KELLER, H.: Effects of staurosporine, K252a and other structurally related protein kinase inhibitors on shape and locomotion of Walker carcinosarcoma cells. Br. J. Cancer, 66, 1992, 1077-1082.